Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI (RIVET)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT01670526
First received: August 1, 2012
Last updated: July 11, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)